CLINICAL_TRIALS
trial_result
· 2015-07-16
Clinical Trial Update: Randomized, Controlled, Double Blind Trial of Eszopiclone for Insomnia Associated With Schizophrenia [NA]
Summary
A randomized, double-blind trial evaluated eszopiclone for insomnia in individuals with schizophrenia, with results posted in July 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yale University | Conditions: Insomnia, Schizophrenia | NA | Status: COMPLETED | Results posted: 2015-07-16